Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions

Cytopathology

Volumn 18, Issue 2, 2007, Pages 112-116

  Matesa N ^a   Samija I ^a   Kusic Z ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Aspiration cytology; Biopsy; CD44v6 antigen; Fine needle; Galectin 3; Reverse transcriptase polymerase chain reaction; Thyroid diseases

Indexed keywords

CD44V6 ANTIGEN; GALECTIN 3;

ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CYTODIAGNOSIS; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; LABORATORY DIAGNOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL SIGNIFICANCE; THYROID FOLLICLE; THYROID PARAFOLLICULAR CELL; THYROID TUMOR; ULTRASOUND;

ADENOMA; ANTIGENS, CD44; BIOLOGICAL MARKERS; BIOPSY, FINE-NEEDLE; CELL ADHESION; FALSE POSITIVE REACTIONS; GALECTIN 3; GLYCOPROTEINS; GOITER, NODULAR; HASHIMOTO DISEASE; HUMANS; MACROPHAGES; OXYPHIL CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID DISEASES; THYROID NEOPLASMS;

EID: 33947681791     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/j.1365-2303.2006.00407.x     Document Type: Article

References (33)

1. Rosai J, Carcangiu MC, DeLellis RA. Tumours of the thyroid gland. In: Atlas of Tumour Pathology. Rosai J (ed.). Washington, DC: AFIP; 1992: pp. 31-50.
2. Nunez C, Mendelsohn G. Fine-needle aspiration biopsy of the thyroid gland. Pathol Annu 1989;24:161-98.
3. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitation and effect. Mayo Clin Proc 1994;69:44-9.
4. Gharib H, Goellner JR. Fine-needle aspiration biopsy of thyroid: an appraisal. Ann Intern Med 1993;118:282-9.
5. McHenry CR, Rosen IB, Walfish PG, Bedard Y. Influence of fine needle aspiration biopsy and frozen section examination on the management of thyroid cancer. Am J Surg 1993;166:353-6.
6. Arturi F, Russo D, Giuffrida D et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small nodes. J Clin Endocrinol Metab 1997;82:1638-41.
7. Russo D, Arturi F, Pontecorvi A, Fileti S. Genetic analysis in fine-needle aspiration of the thyroid: a new tool for the clinic. Trends Endocrinol Metab 1999;10:280-5.
8. Takano T, Miyauchi A, Matsuzuka F et al. Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle for fine needle aspiration biopsy. J Clin Endocrinol Metab 1999;84:951-5.
9. Gasbarri A, Martegani MP, Del Prete F et al. A galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 1999;17:3494-502.
10. Fernandez PL, Merino MJ, Gomez M et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 1997;181:80-6.
11. Orlandi F, Saggiorato E, Pivano G et al. Galectin-3 is presurgical marker of human thyroid carcinoma. Cancer Res 1998;58:3015-20.
12. Inohara H, Honjo Y, Yoshii T et al. Expression of galectin-3 in fine needle aspirates as diagnostic marker differentiating benign from malignant thyroid neoplasm. Cancer 1999;85:2475-84.
13. Kawachi K, Matsushita Y, Yonezowa S et al. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 2000;31:428-33.
14. Bartolazzi A. Improving accuracy of cytology for nodular thyroid lesions. Lancet 2000;355:1661-2.
15. Nascimento MC, Bisi H, Alves VA et al. Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas. Endocr Pathol 2001;12:275-9.
16. Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins: structure and function of a large family of animal lectins. J Biol Chem 1994;269:20807-10.
17. Naor D, Vogt Sionov R, Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 1997;71:241-319.
18. Martins L, Matsuo SE, Ebina KN et al. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumours. J Clin Endocrinol Metab 2002;87:4806-10.
19. Niedziela M, Maceluch J, Korman E. Galectin-3 is not a universal marker of malignancy in thyroid nodular disease in children and adolescents. J Clin Endocrinol Metab 2002;87:4411-5.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
21. Battayani Z, Grob JJ, Xerri L et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995;131:443-7.
22. Ditkoff BA, Marvin MR, Yemul S et al. Detection of circulating thyroid cells in peripheral blood. Surgery 1996;120:959-65.
23. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma is expressed in thyroid nodules with cytological atypia. Histopathology 2002;40:80-7.
24. Collet JF, Hurbain I, Prengel C et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. Br J Cancer 2005;93:1175-81.
25. Kim H, Lin H, Biliran H, Raz A. Cell cycle arrest and inhibition of anoikis in human breast epithelial cells. Cancer Res 1999;59:4148- 54.
26. Herrmann ME, LiVolsi VA, Pasha TL et al. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med 2002;126:710-3.
27. Cherayil BJ, Chaitovitz S, Wong C, Pillai S. Molecular cloning of a human macrophage lectin specific for galactose. Proc Natl Acad Sci U S A 1990;87:7324-8.
28. Frigeri LG, Liu FT. Surface expression of functional IgE binding protein, an endogenous lectin, on mast cells and macrophages. J Immunol 1992;148:861-7.
29. Mills LJ, Poller DN, Yiangou C. Galectin-3 is not useful in thyroid FNA. Cytopathology 2005;16:132-8.
30. Bernet VJ, Anderson J, Vaishnav Y et al. Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2002;87:4792-6.
31. Ermak G, Gerasimov G, Troshina K et al. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and non neoplastic lesions of the human thyroid. Cancer Res 1995;55:4594-8.
32. Bohm JP, Niskanen LK, Pirinen RT et al. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma. J Pathol 2000;192:321-7.
33. Gu J, Daa T, Kashima K, Yokoyama et al. Expression of splice variant of CD44 in thyroid neoplasms derived from follicular cells. Pathol Int 1998;48:184-90.